To generate new immunogens for cancer treatment and prevention, two specific PD-L1-containg peptides fusion proteins PDL1-GMCSF and MSLN-PDL1-GMCSF were designed and synthesized based on the recent method of peptide assembly we developed (13) and cloned them into the pET21a expression vector. This evidence concerns the gene MSLN and cancer.